Advances in GLP-1 and GIP Agonists for Obesity Treatment | Retatrutide News

Research into GLP-1 and GIP receptor agonists, including Retatrutide, is advancing obesity treatment. Eli Lilly is actively involved in developing these...
Clinical Trials · October 18, 2026